Hologic Management

Management Kriterienprüfungen 4/4

Hologic CEO ist Steve MacMillan , ernannt in Dec 2013, hat eine Amtszeit von 10.92 Jahren. Die jährliche Gesamtvergütung beträgt $15.56M , bestehend aus 7.6% Gehalt und 92.4% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.03% der Aktien des Unternehmens, im Wert von $187.69M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 3.8 Jahre bzw. 7.9 Jahre.

Wichtige Informationen

Steve MacMillan

Geschäftsführender

US$15.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts7.6%
Amtszeit als Geschäftsführer10.9yrs
Eigentum des Geschäftsführers1.0%
Durchschnittliche Amtszeit des Managements3.8yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder7.9yrs

Jüngste Management Updates

Recent updates

When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Nov 02
When Should You Buy Hologic, Inc. (NASDAQ:HOLX)?

Hologic: Continued Room Amidst Bolt-On M&A Efforts

Oct 28

Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Oct 17
Hologic (NASDAQ:HOLX) Seems To Use Debt Rather Sparingly

Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Sep 16
Hologic (NASDAQ:HOLX) Has More To Do To Multiply In Value Going Forward

Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Sep 01
Hologic, Inc. (NASDAQ:HOLX) Not Flying Under The Radar

Hologic Has A Lot Of Fine Qualities, But A Discount Valuation Isn't Among Them

Aug 27

Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

Jul 21
Is There Now An Opportunity In Hologic, Inc. (NASDAQ:HOLX)?

These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Jun 20
These 4 Measures Indicate That Hologic (NASDAQ:HOLX) Is Using Debt Reasonably Well

Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

May 22
Returns At Hologic (NASDAQ:HOLX) Appear To Be Weighed Down

Hologic: Women's Health Play Looks Healthier Itself

May 13

Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Apr 19
Getting In Cheap On Hologic, Inc. (NASDAQ:HOLX) Might Be Difficult

Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Apr 05
Calculating The Intrinsic Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Mar 20
Hologic (NASDAQ:HOLX) Has A Pretty Healthy Balance Sheet

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Feb 22
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Hologic: Prospects For Growth As Headwinds Disappear

Feb 11

We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Feb 09
We Think You Can Look Beyond Hologic's (NASDAQ:HOLX) Lackluster Earnings

Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

Feb 06
Hologic, Inc. Just Beat EPS By 32%: Here's What Analysts Think Will Happen Next

We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

Jan 29
We Like These Underlying Return On Capital Trends At Hologic (NASDAQ:HOLX)

The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Dec 30
The Price Is Right For Hologic, Inc. (NASDAQ:HOLX)

Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

Dec 11
Are Investors Undervaluing Hologic, Inc. (NASDAQ:HOLX) By 25%?

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Nov 08
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Oct 25
Should You Think About Buying Hologic, Inc. (NASDAQ:HOLX) Now?

Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Sep 28
Slowing Rates Of Return At Hologic (NASDAQ:HOLX) Leave Little Room For Excitement

Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

Aug 29
Hologic, Inc.'s (NASDAQ:HOLX) Intrinsic Value Is Potentially 35% Above Its Share Price

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Jul 31
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Jul 18
Why Hologic, Inc. (NASDAQ:HOLX) Could Be Worth Watching

Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Jun 21
Return Trends At Hologic (NASDAQ:HOLX) Aren't Appealing

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

May 22
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

Apr 25
We Think Hologic (NASDAQ:HOLX) Can Stay On Top Of Its Debt

What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Apr 10
What Does Hologic, Inc.'s (NASDAQ:HOLX) Share Price Indicate?

Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Mar 13
Hologic's (NASDAQ:HOLX) Returns On Capital Are Heading Higher

Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Feb 14
Calculating The Fair Value Of Hologic, Inc. (NASDAQ:HOLX)

Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Jan 18
Hologic (NASDAQ:HOLX) Seems To Use Debt Quite Sensibly

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Steve MacMillan im Vergleich zu den Einnahmen von Hologic verändert?
DatumGesamtvergütungGehaltUnternehmensgewinne
Jun 29 2024n/an/a

US$702m

Mar 30 2024n/an/a

US$467m

Dec 30 2023n/an/a

US$515m

Sep 30 2023US$16mUS$1m

US$456m

Jul 01 2023n/an/a

US$484m

Apr 01 2023n/an/a

US$753m

Dec 31 2022n/an/a

US$990m

Sep 24 2022US$14mUS$1m

US$1b

Jun 25 2022n/an/a

US$2b

Mar 26 2022n/an/a

US$2b

Dec 25 2021n/an/a

US$2b

Sep 25 2021US$15mUS$1m

US$2b

Jun 26 2021n/an/a

US$2b

Mar 27 2021n/an/a

US$2b

Dec 26 2020n/an/a

US$1b

Sep 26 2020US$14mUS$1m

US$1b

Jun 27 2020n/an/a

US$497m

Mar 28 2020n/an/a

US$453m

Dec 28 2019n/an/a

US$84m

Sep 28 2019US$12mUS$1m

-US$204m

Jun 29 2019n/an/a

-US$30m

Mar 30 2019n/an/a

-US$11m

Dec 29 2018n/an/a

-US$419m

Sep 29 2018US$42mUS$1m

-US$111m

Vergütung im Vergleich zum Markt: SteveDie Gesamtvergütung ($USD15.56M) liegt im Durchschnitt der Unternehmen ähnlicher Größe auf dem Markt US ($USD12.74M).

Entschädigung vs. Einkommen: SteveDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.


Geschäftsführer

Steve MacMillan (60 yo)

10.9yrs

Amtszeit

US$15,555,032

Vergütung

Mr. Stephen P. MacMillan, also known as Steve, serves as an Independent Chairman of the Board at Illumina, Inc. from June 02, 2023. He has been the Chairman of the Board at Hologic Inc. since June 17, 2015...


Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Stephen MacMillan
Chairman10.9yrsUS$15.56m1.03%
$ 187.7m
Karleen Oberton
Chief Financial Officer6.3yrsUS$3.93m0.045%
$ 8.1m
Essex Mitchell
Chief Operating Officerless than a yearUS$2.17m0.013%
$ 2.5m
John Griffin
General Counsel9.8yrsUS$3.34m0.079%
$ 14.4m
Jan Verstreken
Group President of Internationalno dataUS$3.52m0.045%
$ 8.2m
Paul Malenchini
Chief Information Officer3.3yrskeine Datenkeine Daten
Ryan Simon
Vice President of Investor Relationsno datakeine Datenkeine Daten
Diana De Walt
Senior Vice President of Global Human Resourcesless than a yearkeine Datenkeine Daten
Monica Berthelot
VP & Chief of Staff10.8yrskeine Datenkeine Daten
Erik Anderson
Division President of Breast & Skeletal Health Solutions4.3yrskeine Daten0.010%
$ 1.9m
Jennifer Schneiders
President of Diagnostics Solutions1.6yrskeine Daten0.0054%
$ 991.3k
Scott Christensen
Senior Vice President of Global Supply Chain1.1yrskeine Datenkeine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

56yo

Durchschnittliches Alter

Erfahrenes Management: HOLXDas Führungsteam des Unternehmens gilt als erfahren (3.8 Jahre durchschnittliche Betriebszugehörigkeit).


Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Stephen MacMillan
Chairman10.9yrsUS$15.56m1.03%
$ 187.7m
Scott Garrett
Independent Director11.5yrsUS$339.96k0.018%
$ 3.3m
Sally Crawford
Independent Director17.1yrsUS$374.96k0.057%
$ 10.3m
Stacey Stewart
Independent Director1.8yrsUS$338.44k0.000070%
$ 12.8k
Ludwig Hantson
Independent Director6yrsUS$319.96k0.0025%
$ 458.2k
Charles Dockendorff
Independent Director7.5yrsUS$344.96k0.0066%
$ 1.2m
Christiana Stamoulis
Independent Director13yrsUS$319.96k0.019%
$ 3.5m
Amy Wendell
Lead Independent Director7.9yrsUS$319.96k0.0076%
$ 1.4m
Nanaz Mohtashami
Independent Director1.2yrsUS$128.96k0.00032%
$ 58.4k

7.9yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: HOLXDie Vorstandsmitglieder gelten als erfahren (7.9 Jahre durchschnittliche Amtszeit).